Telemonitoring of home dialysis utilizing a smart biomimetic arteriovenous graft (TELEGRAFT)
Telemonitoring of home dialysis utilizing a smart biomimetic arteriovenous graft (TELEGRAFT)
批准号:
10069389
负责人:
金额:
$45.37万
依托单位:
依托单位国家:
英国
项目类别:
EU-Funded
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Clinical need: 10% of the population worldwide is affected by chronic kidney disease (CKD) and millions die each year because they do not have access to treatment. Giving global shortage of kidney donors, the vast majority of patients rely on hemodialysis (HD). Over 2.6M people worldwide currently receive HD to stay alive, yet this number may only represent 10% of people needing treatment. Solution: Up to 70% of current arteriovenous grafts (AVG) fail in the first year after implantation. This is primarily due to thrombosis, luminal scar formation, and infection. In our ground-breaking new AVG, biomimicking zwitterions prevent thrombosis, drug delivery prevents scar formation and infection, and an ECM coating ensures fast tissue integration allowing early HD. Smart: TeleGraft comprises two diagnostic tools to monitor and prevent device complication. Pressure transmitters are used to monitor blood flow and optical sensors to detect inflammation and infections. The data is processed by AI machine learning models and displayed in an easy to understand dashboard for healthcare professionals. The data allows online telemonitoring and consultations by remote healthcare professionals. This makes home dialysis safe for patients, even in areas with poor infrastructure, where patients live far from HD clinics. Surgical implantation: The TeleGraft system will be demonstrated in an operational environment through a 2-stage randomized clinical trial enrolling 60 patients at 5 hospitals across Europe and through a home HD field study. Resource constrained setting: (1) In low and middle income countries, TeleGraft will substitute complicated and expensive kidney transplantation and allow simpler and cheap implantation of AVG for HD. (2) TeleGraft is the only solution with diagnostic tools allowing real-time online detection and remote monitoring of complications and device failure. This allows transition from HD at the hospital to the resource constrained home setting.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
基于AI-Home模式的脑肿瘤术后患者康复体系构建及实证研究
-
批准号:2026JJ82675
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王睿
-
依托单位: